U.S. Electrical Stock News

Q1 2026 headline results and setup Corteva (CTVA) opened 2026 with Q1 revenue of US$4.9 billion and basic EPS of US$1.07, with trailing twelve month net income of US$1.25 billion giving investors a fuller view of the current earnings run rate. The company reported quarterly revenue of US$4.42 billion in Q1 2025 and US$4.91 billion in Q1 2026, while basic EPS moved from US$0.97 to US$1.07 over the same period as trailing net profit margins held close to 7%. With earnings growth forecasts...

Solventum (SOLV) opened Q1 2026 with revenue of US$2.0 billion and basic EPS of US$0.07, putting fresh numbers on the table for investors focused on how its earnings profile is evolving. Over the past few reporting periods, revenue has moved between US$2.1 billion in Q1 2025 and US$2.0 billion in Q1 2026, while basic EPS shifted from US$0.79 in Q1 2025 to US$0.07 in the latest quarter, with the trailing twelve months showing revenue of US$8.3 billion and basic EPS of US$8.22. This mix of...

Standard BioTools (LAB) has kicked off Q1 2026 with revenue of about US$21.1 million and a basic EPS loss of roughly US$0.04. This sets a cautious tone around how much of that top line is flowing through to the bottom line. The company has seen quarterly revenue move between roughly US$19.6 million and US$24.8 million since Q4 2024, while basic EPS has ranged from a loss of about US$0.08 to a profit of roughly US$0.04 over the same period. This underscores how sensitive margins have been to...

Tempus AI (TEM) opened Q1 2026 with revenue of US$348.1 million and a basic EPS loss of US$0.70, while trailing 12 month figures show US$1.4 billion in revenue and a basic EPS loss of US$1.72. This keeps the focus firmly on scaling rather than profitability. Over recent quarters the company has seen revenue move from US$255.7 million in Q1 2025 to US$348.1 million in Q1 2026, with basic EPS losses ranging between US$0.25 and US$0.70 per quarter across that period. For you as an investor, this...

CRISPR Therapeutics (NasdaqGM:CRSP) has expanded its lead CAR-T program, zugo-cel, into new autoimmune disease indications. The company advanced multiple in vivo liver-directed gene editing and siRNA programs into clinical development. CASGEVY, its gene-editing therapy, continues to see commercial traction, and a recent regulatory filing aims to extend its label to younger pediatric patients. A major convertible notes offering has strengthened the balance sheet and is funding a broader...

Intapp (NasdaqGS:INTA) has reported Q3 2026 revenue of US$146.0 million with a basic EPS loss of US$0.20, alongside net income excluding extra items of a US$15.5 million loss. The company has seen quarterly revenue progress from US$121.2 million in Q2 2025 to US$129.1 million in Q3 2025 and US$146.0 million in Q3 2026. Over the same periods, basic EPS moved from a US$0.13 loss to a US$0.04 loss and then a US$0.20 loss, setting up this quarter as another test of how quickly margins can move...

Bowman Consulting Group (BWMN) opened Q1 2026 with revenue of US$126.5 million and a basic EPS loss of US$0.22, alongside trailing twelve month EPS of US$0.62 on US$503.6 million of revenue. Over the past year, the company has seen revenue move from US$444.6 million to US$503.6 million on a trailing basis, while EPS shifted from US$0.16 to US$0.62, giving investors a clear view of how the top line and per share earnings have tracked together. Taken together with a trailing net margin that now...

Ferroglobe (NasdaqCM:GSM) opened 2026 with Q1 revenue of US$347.7 million and a basic EPS loss of US$0.04, alongside a trailing 12 month net loss of US$111.3 million on revenue of US$1.4 billion. Over recent quarters the company has seen revenue move between US$307.2 million and US$386.9 million, while quarterly basic EPS has ranged from a loss of US$0.04 to a loss of US$0.43 as profitability remained under pressure and margins stayed in the red. See our full analysis for Ferroglobe. With the...

BeOne Medicines (ONC) opened 2026 with Q1 revenue of US$1.5b and basic EPS of US$2.05, alongside net income of US$227.4 million. This sets a clear marker for how the business is currently converting its top line into earnings. Over the past year, the company has seen quarterly revenue move from US$1.1b in Q1 2025 to US$1.5b in Q1 2026, while basic EPS shifted from essentially flat at US$0.01 to US$2.05. This gives investors a straightforward read on how profitability is tracking against the...

Hackett Group (HCKT) has opened Q1 2026 with total revenue of US$67.8 million and basic EPS of US$0.17, alongside trailing twelve month revenue of US$292.5 million and EPS of US$0.53. These figures sit against a net profit margin of 4.8% versus 7.8% a year earlier. Over recent quarters the company has seen quarterly revenue move from US$76.2 million in Q1 2025 to US$77.6 million in Q2 2025, US$72.2 million in Q3 2025 and US$74.8 million in Q4 2025, before landing at US$67.8 million in Q1...

UWM Holdings (UWMC) opened 2026 with Q1 revenue of US$752.9 million and basic EPS of US$0.09, alongside trailing twelve month revenue of US$4.0 billion and basic EPS of US$0.27 that reflect the company’s move into profitability over the past year. The company has seen quarterly revenue range from US$613.4 million in Q1 2025 to US$1.0 billion in Q4 2025, with EPS swinging from a loss of US$0.08 in Q1 2025 to a profit of US$0.11 in Q2 2025 before settling at US$0.09 this quarter. This sets up a...

Lumentum Holdings (LITE) opened Q3 2026 with revenue of US$808.4 million and basic EPS of US$1.99, supported by net income of US$142.5 million. The company has seen revenue move from US$402.2 million in Q2 2025 to US$808.4 million in Q3 2026, while basic EPS shifted from a loss of US$0.88 to a gain of US$1.99. Trailing twelve month EPS stands at US$6.21 on revenue of US$2.5 billion. This combination of profitability and revenue scale puts the focus firmly on margins as results season...

Wondering if Bath & Body Works at around US$19.20 is a bargain or a value trap? This article focuses squarely on what the current price may be implying about the stock. The stock has risen 4.7% over the last week and 6.0% over the last month, yet year to date it shows a 7.4% decline and the 1 year return stands at 34.8% lower. This pattern may catch the eye of value focused investors. Recent coverage around specialty retail and consumer discretionary spending has put companies like Bath &...

Lineage (LINE) opened Q1 2026 with revenue of US$1.3 billion and a basic EPS loss of US$0.20. On a trailing 12 month basis, revenue stood at US$5.4 billion and basic EPS was a loss of US$0.63, alongside trailing 12 month revenue growth of 4.6% a year versus 11.3% for the broader US market. Over recent quarters, revenue has moved in a narrow band between US$1.29 billion and US$1.38 billion, while quarterly basic EPS has ranged from a loss of US$0.44 to a small profit of roughly US$0.03. This...

Some investors may be considering whether Douglas Dynamics at around US$45.42 is still offering value after a strong run, or whether much of the opportunity is already reflected in the current share price. The stock has recorded returns of 2.8% over 7 days, 8.1% over 30 days, 37.7% year to date and 83.6% over 1 year. This puts recent price action front and center for anyone weighing the balance between potential and risk. Recent coverage has highlighted Douglas Dynamics as a Machinery sector...

Uber Technologies (UBER) opened 2026 with Q1 revenue of US$13.2b and basic EPS of US$0.13, setting the tone for how investors assess profit quality after a year in which trailing twelve month EPS sat at US$4.12. The company reported quarterly revenue increasing from US$11.5b in Q1 2025 to US$13.2b in Q1 2026, while basic EPS moved from US$0.85 to US$0.13 over the same period, against a trailing net income base of US$8.5b. With margins firmly in focus after the past year's compression, this...

Medline (MDLN) opened 2026 by reporting Q1 revenue of about US$7.4b and net income of US$129m, with basic EPS of US$0.16 against a trailing twelve month EPS of US$1.14 that was generated on US$29.1b of revenue and US$966m of net income. Over the past few quarters the company has seen revenue move from US$6.8b in Q4 2024 to US$6.8b in Q1 2025, then to US$7.1b in Q3 2025, US$7.8b in Q4 2025 and finally US$7.4b in Q1 2026, while quarterly basic EPS shifted from US$0.02 in Q4 2024 to US$0.02 in...

If you are wondering whether IPG Photonics at around US$101.94 is a bargain or a potential value trap, you are not alone. The stock has pulled back 10.0% over the last week and 7.7% over the last month, yet it still stands 36.2% higher year to date and 76.1% over the last year, compared with 3-year and 5-year returns of 9.5% and 45.6% declines. Those swings come alongside ongoing attention on IPG Photonics as a key player in high performance fiber lasers and related photonics solutions. This...

CS Disco (LAW) has reported Q1 2026 revenue of US$41.9 million with a basic EPS loss of US$0.15, setting the stage for another quarter where investors are weighing top line progress against ongoing losses. The company has seen quarterly revenue move from US$36.7 million in Q1 2025 to US$41.9 million in Q1 2026, while quarterly basic EPS over that period has ranged from a loss of US$0.19 to a loss of US$0.15, keeping the focus firmly on when margins might begin to meaningfully narrow. With the...

Investors may be wondering if APA at US$38.30 still offers value after a strong run, or if most of the opportunity is already in the price. The stock has a 7 day return of a 5.0% decline and a 30 day return of an 11.0% decline, yet it shows a 51.0% return year to date and 157.7% over the last year, which can change how investors think about both upside and risk. Over the last three and five years, APA has returns of 30.8% and 109.7%. These figures keep the stock on many watchlists even after...

GXO Logistics (GXO) opened 2026 with Q1 revenue of about US$3.3b and basic EPS of US$0.03, with net income excluding extra items at US$4m, setting a measured tone for investors reviewing the latest print. The company has seen quarterly revenue move from US$3.0b in Q1 2025 to roughly US$3.3b in Q1 2026, while basic EPS shifted from a loss of US$0.81 to a small profit and trailing twelve month EPS reached US$1.15, giving a clearer line of sight on how earnings have tracked across recent...

InnovAge Holding (INNV) has posted a mixed Q3 2026 result, with revenue at US$251.9 million and a basic EPS loss of US$0.22 alongside net income of US$29.5 million in the red. The company’s revenue increased from US$218.1 million in Q3 2025 to US$251.9 million in Q3 2026, while quarterly EPS moved from a loss of US$0.08 to a loss of US$0.22 over the same period. This sets up a narrative that now focuses on how quickly margins can be repaired to align with the growth in the top line. See our...

MPLX (MPLX) opened Q1 2026 with revenue of US$3.0 billion, basic EPS of US$0.90 and net income of US$912 million, setting a clear marker for how the year is starting. Over the past year, the company has seen quarterly revenue range from US$2.8 billion to just over US$3.0 billion. Basic EPS moved between roughly US$0.90 and US$1.52, giving investors a consistent stream of earnings to track against the current share price of US$55.66. With trailing net margins around 40% and earnings growth...

SharkNinja (SN) opened Q1 2026 with revenue of about US$1.4b and basic EPS of US$0.86, with trailing twelve month revenue of roughly US$6.6b and EPS of US$4.99 framing the latest quarter against a fuller earnings base. Over the past few quarters, revenue has moved from US$1.22b in Q1 2025 to US$1.41b in Q1 2026, while quarterly EPS shifted from US$0.84 to US$0.86 and trailing twelve month EPS went from US$3.19 at Q1 2025 to US$4.99 at Q1 2026. Together, these figures give investors a clearer...